# Peri-Operative Changes of Inflammatory Markers and Their Implications in Pulmonary Endarterectomy

**Authors:** Qianqian Liu, Ziru Zhao, Jing Yang, Yunshan Cao, Min Zhang

PMC · DOI: 10.31083/j.rcm2311357 · 2022-10-25

## TL;DR

This paper reviews how inflammatory markers change before and after pulmonary endarterectomy surgery and their possible significance.

## Contribution

The study compiles recent data on inflammatory markers during pulmonary endarterectomy to explore their potential implications.

## Key findings

- Levels of inflammatory factors change during the peri-operative period of PEA.
- The specific role of these inflammatory markers remains unclear but may be relevant.
- The study aims to understand the potential implications of these changes.

## Abstract

Pulmonary endarterectomy (PEA) is used to 
treat chronic thromboembolic pulmonary hypertension (CTEPH) patients, and it can 
effectively remove organized thrombotic materials and proliferative intima as 
well as improve hemodynamics. It has been reported that the levels of several 
inflammatory factors were altered in the peri-operative period of 
PEA. Even though their specific role remains unknown, this could 
have some relevance. In this study, we reviewed the recently published data 
addressing these factors in PEA, attempting to understand their potential 
implications.

## Linked entities

- **Diseases:** chronic thromboembolic pulmonary hypertension (MONDO:0013024)

## Full-text entities

- **Diseases:** thrombotic (MESH:D013927), Inflammatory (MESH:D007249), CTEPH (MESH:D011655)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11269080/full.md

---
Source: https://tomesphere.com/paper/PMC11269080